🇮🇳IN
Sign In
BR

BROOKS

NSE

Brooks Laboratories Limited

₹64.56

+1.50(+2.38%)

Group Companies

Foreign Flows

sector level — not this stock
Healthcare sector+₹3 Crnet foreign buying
2026-09-16 to 2026-09-end

This is the flow into the whole Healthcare sector, not into BROOKS. We report it at the level it is measured — attributing a sector figure to one company would be inventing a number nobody published.

Supply Chain

suppliers and customers in the graph

Relationship Network

directors, institutions, group entities

Macro Sensitivity

rates, currency, commodities

Revenue by Segment

Business Group

Geographic Exposure

revenue, imports, currency

Scenario analysis

stated assumptions, shown workings

BROOKS exposure summary

In its latest segment disclosure (Mar 2026), b) Manufacturing accounted for 100.0% of segment revenue.

Largest segmentb) Manufacturing · 100.0%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer